News & Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Microbiology-Immunology. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
A viral protein of the Epstein-Barr virus previously thought to mimic immune cell receptor signaling actually rewires intracellular signaling in infected cells, promoting viral cell survival and proliferation.
Treatment-resistant breast cancer could be made vulnerable to immunotherapy by flipping a metabolic “switch,” according to a new Northwestern Medicine study.
Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.
Northwestern Medicine investigators have discovered that a specialized protein associated with the microtubules of a cell helps facilitate and regulate early stages of HIV infection.
Using an artificial intelligence cell classification technique, Northwestern Medicine investigators have found that viruses can control structural and genetic polarity inside the cell nucleus.
Blocking the frontline immune response could improve vaccines against viral diseases such as coronaviruses, according to a Northwestern Medicine study.
By rebooting previous research related to SARS, the Center for Structural Genomics of Infectious Diseases (CSGID) was quickly able to begin investigating the protein structures of the virus with the goal of finding new drug targets for COVID-19.
- Microbiologist Dr. Karla Satchell: ‘A little bit of protection and an okay vaccine is going to get us a long way in this epidemic’07.22.2020A chimeric toxin slowed tumor growth in mouse models of human breast and colon cancer, according to a Northwestern Medicine study published in Proceedings of the National Academy of the Sciences (PNAS).
An emerging cancer treatment also helps prevent cells from turning into viral factories by interfering with HIV infection processes inside the cell, according to a recent study.
A drug originally designed as cancer therapy virtually eliminated allergic reactions in moderate cases and significantly lessened the risk of death in severe cases, according to a new study in animal models.
- 07.06.2020A chimeric toxin slowed tumor growth in mouse models of human breast and colon cancer, according to a Northwestern Medicine study published in Proceedings of the National Academy of the Sciences (PNAS).
A specialized subset of rare immune cells called plasmacytoid dendritic cells may promote antitumor immunity, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
A recent study has found that the gallbladder may play a crucial role in the transmission of a common infection found in hospital settings, according to findings published in Nature Communications.